You have no items in your shopping cart.
You have no items in your shopping cart.
| Catalog Number | orb1805427 |
|---|---|
| Category | Antibodies |
| Description | Anti-ERBB3/HER3 Reference Antibodybody and Dxd, a topoisomerase I inhibitor, used for the study of non-small cell lung cancer. |
| Target | ERBB3 / HER3 |
| Clonality | Recombinant |
| Conjugation | DXD |
| Reactivity | Human |
| Concentration | Batch dependent |
| Buffer/Preservatives | 100 mM Proline/Acetic acid 20mM Arginine pH 5.0 |
| Purity | >95% |
| Purification | Protein A |
| UniProt ID | P21860 |
| MW | 155.2 kDa |
| Tested applications | ELISA, FA, FACS, In vivo |
| Antibody Type | Recombinant Antibody |
| Expression System | CHO |
| Endotoxins | <0.001 EU/ug |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
| Note | For research use only |

Anti-ERBB3/ HER3 Reference Antibody (patritumab deruxtecan) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-ERBB3/ HER3 Reference Antibody (patritumab deruxtecan)is more than 99.19% ;determined by SEC-HPLC.

Immobilized human HER3 His at 2 μg/mL can bind Anti-ERBB3/ HER3 Reference Antibody (patritumab deruxtecan);EC50=0.044μg/mL.
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review